Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946231 · ClinicalTrials.gov registry record
Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 187
- Enrollment target
NCT00946231: Completed study, sponsored by Abbott RDx Cardiometabolic.
NCT00946231 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946231 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart failure. Enrolled subjects will be trained on the use of the Triage Touch meter for fingerstick BNP assessment; these subjects will then test their BNP levels daily using the Triage Touch product for approximately 60 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-10 |
What the finished NCT00946231 record still lists
NCT00946231 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00946231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00946231 about?
NCT00946231 is a clinical study titled "Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home". The HABIT clinical study is being performed to determine the benefit and optimal frequency for at home testing of B-type natriuretic peptide (BNP) for heart failure patients following hospitalization from decompensation. Subjects will be enrolled following hospitalization for decompensated heart fai...
What is the current status of trial NCT00946231?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2009-07. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00946231?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia